| +0.62 / +1.81%|
The 5 analysts offering 12-month price forecasts for Epizyme Inc have a median target of 45.00, with a high estimate of 52.00 and a low estimate of 40.00. The median estimate represents a +29.31% increase from the last price of 34.80.
The current consensus among 6 polled investment analysts is to Buy stock in Epizyme Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.